Kuusisto, Finland

Jukka Salmia

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jukka Salmia: Innovator in Pharmaceutical Compositions

Introduction

Jukka Salmia is a notable inventor based in Kuusisto, Finland. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on triphenylethylene antiestrogens. With a total of 3 patents to his name, Salmia's work has the potential to impact medical treatments significantly.

Latest Patents

Salmia's latest patents include innovative aqueous compositions of nonsteroidal triphenylethylene antiestrogens for pharmaceutical use. These compositions utilize a solubility-enhancing agent, which is a pharmaceutically acceptable mono- or dicarboxylic acid with 1-5 carbon atoms. The carbon chain may also contain hydroxyl, oxo, or halogen substituents, or a corresponding anion, along with methanesulfonic acid or its anion. Additionally, these compositions may include organic water-miscible co-solvents such as polyethylene glycol (PEG), propylene glycol, ethanol, or isopropanol.

Career Highlights

Jukka Salmia is currently associated with Orion Corporation, where he continues to develop his innovative ideas in pharmaceutical formulations. His work is characterized by a commitment to enhancing the solubility and efficacy of antiestrogen compounds, which are crucial in various therapeutic applications.

Collaborations

Salmia has collaborated with esteemed colleagues, including Kaija Af Ursin and Heikki Niskanen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Jukka Salmia's contributions to pharmaceutical innovations, particularly in the area of triphenylethylene antiestrogens, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…